Literature DB >> 12613573

The role of cytokines as effectors of tissue destruction in autoimmunity.

Thomas W H Kay1, Rima Darwiche, Windy Irawaty, Mark M W Chong, Helen L Pennington, Helen E Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12613573     DOI： 10.1007/978-1-4615-0171-8_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  6 in total

Review 1.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 2.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 3.  Mechanisms of diabetic autoimmunity: I--the inductive interface between islets and the immune system at onset of inflammation.

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 4.  Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice.

Authors:  Y Yang; P Santamaria
Journal:  Diabetologia       Date:  2003-10-28       Impact factor: 10.122

5.  Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1.

Authors:  Sarah A Steer; Anna L Scarim; Kari T Chambers; John A Corbett
Journal:  PLoS Med       Date:  2005-12-20       Impact factor: 11.069

6.  Fas/Fas-Ligand Interaction As a Mechanism of Immune Homeostasis and β-Cell Cytotoxicity: Enforcement Rather Than Neutralization for Treatment of Type 1 Diabetes.

Authors:  Esma S Yolcu; Haval Shirwan; Nadir Askenasy
Journal:  Front Immunol       Date:  2017-03-27       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.